{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:52:54Z","timestamp":1792403574457,"version":"4.4.0"},"reference-count":86,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["joe.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>The forkhead box O family consists of FoxO1, FoxO3, FoxO4 and FoxO6 proteins in mammals. Expressed ubiquitously in the body, the four FoxO isoforms share in common the amino DNA-binding domain, known as \u2018forkhead box\u2019 domain. They mediate the inhibitory action of insulin or insulin-like growth factor on key functions involved in cell metabolism, growth, differentiation, oxidative stress, senescence, autophagy and aging. Genetic mutations in FoxO genes or abnormal expression of FoxO proteins are associated with metabolic disease, cancer or altered lifespan in humans and animals. Of the FoxO family, FoxO6 is the least characterized member and is shown to play pivotal roles in the liver, skeletal muscle and brain. Altered FoxO6 expression is associated with the pathogenesis of insulin resistance, dietary obesity and type 2 diabetes and risk of neurodegeneration disease. FoxO6 is evolutionally divergent from other FoxO isoforms. FoxO6 mediates insulin action on target genes in a mechanism that is fundamentally different from other FoxO members. Here, we focus our review on the role of FoxO6, in contrast with other FoxO isoforms, in health and disease. We review the distinctive mechanism by which FoxO6 integrates insulin signaling to hepatic glucose and lipid metabolism. We highlight the importance of FoxO6 dysregulation in the dual pathogenesis of fasting hyperglycemia and hyperlipidemia in diabetes. We review the role of FoxO6 in memory consolidation and its contribution to neurodegeneration disease and aging. We discuss the potential therapeutic option of pharmacological FoxO6 inhibition for improving glucose and lipid metabolism in diabetes.<\/jats:p>","DOI":"10.1530\/joe-17-0002","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T20:10:46Z","timestamp":1487362246000},"page":"R67-R79","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":328,"title":["FoxO integration of insulin signaling with glucose and lipid metabolism"],"prefix":"10.1530","volume":"233","author":[{"given":"Sojin","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Endocrinology and DiabetesDepartment of Pediatrics, Children\u2019s Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Henry","family":"Dong","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and DiabetesDepartment of Pediatrics, Children\u2019s Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2017032117200644000_233.2.R67.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(04)00452-0"},{"key":"2017032117200644000_233.2.R67.2","first-page":"E1020","article-title":"Peripheral effects of insulin dominate suppression of fasting hepatic glucose production","volume":"258","author":"Ader","year":"1990","journal-title":"American Journal of Physiology"},{"key":"2017032117200644000_233.2.R67.3","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419992"},{"key":"2017032117200644000_233.2.R67.4","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2008.0827"},{"key":"2017032117200644000_233.2.R67.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2005.03.010"},{"key":"2017032117200644000_233.2.R67.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2008.06.013"},{"key":"2017032117200644000_233.2.R67.7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.650994"},{"key":"2017032117200644000_233.2.R67.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1086336"},{"key":"2017032117200644000_233.2.R67.9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200525152"},{"key":"2017032117200644000_233.2.R67.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2009.04.004"},{"key":"2017032117200644000_233.2.R67.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.04.007"},{"key":"2017032117200644000_233.2.R67.12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/BSR20130031","article-title":"FoxO6 and PGC-1alpha form a regulatory loop in myogenic cells","volume":"33","author":"Chung","year":"2013","journal-title":"Bioscience Reports"},{"key":"2017032117200644000_233.2.R67.13","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1276"},{"key":"2017032117200644000_233.2.R67.14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.celrep.2016.12.029","article-title":"Nutritional programming of lifespan by FOXO inhibition on sugar-rich diets","volume":"18","author":"Dobson","year":"2017","journal-title":"Cell Reports"},{"key":"2017032117200644000_233.2.R67.15","doi-asserted-by":"publisher","DOI":"10.1038\/nature07975"},{"key":"2017032117200644000_233.2.R67.16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2741\/3301","article-title":"Current strategies for the inhibition of hepatic glucose production in type 2 diabetes","volume":"14","author":"Edgerton","year":"2009","journal-title":"Frontiers in Bioscience"},{"key":"2017032117200644000_233.2.R67.17","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.2.292"},{"key":"2017032117200644000_233.2.R67.18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600476"},{"key":"2017032117200644000_233.2.R67.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1109083"},{"key":"2017032117200644000_233.2.R67.20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809594106"},{"key":"2017032117200644000_233.2.R67.21","doi-asserted-by":"publisher","DOI":"10.1042\/bj3490629"},{"key":"2017032117200644000_233.2.R67.22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M314214200"},{"key":"2017032117200644000_233.2.R67.23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098219"},{"key":"2017032117200644000_233.2.R67.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2007.00362.x"},{"key":"2017032117200644000_233.2.R67.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(00)89054-6"},{"key":"2017032117200644000_233.2.R67.26","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.8.2224"},{"key":"2017032117200644000_233.2.R67.27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C110.175851"},{"key":"2017032117200644000_233.2.R67.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.modgep.2005.07.003"},{"key":"2017032117200644000_233.2.R67.29","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.20.1.365"},{"key":"2017032117200644000_233.2.R67.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400093101"},{"key":"2017032117200644000_233.2.R67.31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-2275(20)30121-8","article-title":"Microsomal triglyceride transfer protein is essential for hepatic secretion of apoB-100 and apoB-48 but not triglyceride","volume":"43","author":"Hui","year":"2002","journal-title":"Journal of Lipid Research"},{"key":"2017032117200644000_233.2.R67.32","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R200014-JLR200"},{"key":"2017032117200644000_233.2.R67.33","doi-asserted-by":"publisher","DOI":"10.1038\/nature02549"},{"key":"2017032117200644000_233.2.R67.34","doi-asserted-by":"publisher","DOI":"10.1038\/ncb951"},{"key":"2017032117200644000_233.2.R67.35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302804200"},{"key":"2017032117200644000_233.2.R67.36","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1038\/ncomms12180","article-title":"SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding","volume":"7","author":"Jang","year":"2016","journal-title":"Nature Communications"},{"key":"2017032117200644000_233.2.R67.37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00492.2002"},{"key":"2017032117200644000_233.2.R67.38","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.20.6882"},{"key":"2017032117200644000_233.2.R67.39","doi-asserted-by":"publisher","DOI":"10.1172\/jci32914"},{"key":"2017032117200644000_233.2.R67.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.01.003"},{"key":"2017032117200644000_233.2.R67.41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801011200"},{"key":"2017032117200644000_233.2.R67.42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.473082"},{"key":"2017032117200644000_233.2.R67.43","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0548"},{"key":"2017032117200644000_233.2.R67.44","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1210\/en.2013-1856","article-title":"FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver","volume":"155","author":"Kim","year":"2014","journal-title":"Endocrinology"},{"key":"2017032117200644000_233.2.R67.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.08.004"},{"key":"2017032117200644000_233.2.R67.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2011.00698.x"},{"key":"2017032117200644000_233.2.R67.47","doi-asserted-by":"publisher","DOI":"10.1038\/nature01036"},{"key":"2017032117200644000_233.2.R67.48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083614"},{"key":"2017032117200644000_233.2.R67.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.03.046"},{"key":"2017032117200644000_233.2.R67.50","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp459"},{"key":"2017032117200644000_233.2.R67.51","doi-asserted-by":"publisher","DOI":"10.1038\/nature00904"},{"key":"2017032117200644000_233.2.R67.52","doi-asserted-by":"publisher","DOI":"10.1038\/nature07349"},{"key":"2017032117200644000_233.2.R67.53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406302200"},{"key":"2017032117200644000_233.2.R67.54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27047"},{"key":"2017032117200644000_233.2.R67.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.08.006"},{"key":"2017032117200644000_233.2.R67.56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1934283100"},{"key":"2017032117200644000_233.2.R67.57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2008.00373.x"},{"key":"2017032117200644000_233.2.R67.58","doi-asserted-by":"publisher","DOI":"10.1126\/science.1173388"},{"key":"2017032117200644000_233.2.R67.59","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3071"},{"key":"2017032117200644000_233.2.R67.60","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/oby.21236","article-title":"Assessing FOXO1A as a potential susceptibility locus for type 2 diabetes and obesity in American Indians","volume":"23","author":"Muller","year":"2015","journal-title":"Obesity"},{"key":"2017032117200644000_233.2.R67.61","doi-asserted-by":"publisher","DOI":"10.1038\/nature01789"},{"key":"2017032117200644000_233.2.R67.62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1048"},{"key":"2017032117200644000_233.2.R67.63","doi-asserted-by":"crossref","unstructured":"O-Sullivan I Zhang W Wasserman DH Liew CW Liu J Paik J DePinho RA Stolz DB Kahn CR Schwartz MW 2015 FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nature Communications 6 7079. (doi:10.1038\/ncomms8079)","DOI":"10.1038\/ncomms8079"},{"key":"2017032117200644000_233.2.R67.64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2009.00493.x"},{"key":"2017032117200644000_233.2.R67.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.012"},{"key":"2017032117200644000_233.2.R67.66","doi-asserted-by":"publisher","DOI":"10.2337\/diab.36.5.607"},{"key":"2017032117200644000_233.2.R67.67","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0541"},{"key":"2017032117200644000_233.2.R67.68","doi-asserted-by":"publisher","DOI":"10.1101\/gad.208926.112"},{"key":"2017032117200644000_233.2.R67.69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812547106"},{"key":"2017032117200644000_233.2.R67.70","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12340"},{"key":"2017032117200644000_233.2.R67.71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2010.00627.x"},{"key":"2017032117200644000_233.2.R67.72","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32832b3f4c"},{"key":"2017032117200644000_233.2.R67.73","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.111.241463"},{"key":"2017032117200644000_233.2.R67.74","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300276-JLR200"},{"key":"2017032117200644000_233.2.R67.75","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-005-0772-7"},{"key":"2017032117200644000_233.2.R67.76","doi-asserted-by":"crossref","unstructured":"Tatar M 2005 Comment on \u2018long-lived Drosophila with overexpressed dFOXO in adult fat body\u2019. Science 307 675; author reply 675. (doi:10.1126\/science.1104721)","DOI":"10.1126\/science.1104721"},{"key":"2017032117200644000_233.2.R67.77","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1038\/ncomms8078","article-title":"Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo","volume":"6","author":"Titchenell","year":"2015","journal-title":"Nature Communications"},{"key":"2017032117200644000_233.2.R67.78","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0481"},{"key":"2017032117200644000_233.2.R67.79","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.40.030178.001515"},{"key":"2017032117200644000_233.2.R67.80","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.27.061406.093806"},{"key":"2017032117200644000_233.2.R67.81","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2148-9-222","article-title":"FoxO gene family evolution in vertebrates","volume":"9","author":"Wang","year":"2009","journal-title":"BMC Evolutionary Biology"},{"key":"2017032117200644000_233.2.R67.82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801030105"},{"key":"2017032117200644000_233.2.R67.83","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80611-X"},{"key":"2017032117200644000_233.2.R67.84","first-page":"340","article-title":"Central FoxO3a and FoxO6 expression is down-regulated in obesity induced diabetes but not in aging","volume":"120","author":"Zemva","year":"2012","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"key":"2017032117200644000_233.2.R67.85","doi-asserted-by":"publisher","DOI":"10.1210\/en.2015-1852"},{"key":"2017032117200644000_233.2.R67.86","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2069"}],"container-title":["Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/233\/2\/R67.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/233\/2\/R67.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:55:51Z","timestamp":1784555751000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/joe\/article\/233\/2\/R67-R79\/22936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":86,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/joe-17-0002","relation":{},"ISSN":["0022-0795","1479-6805"],"issn-type":[{"value":"0022-0795","type":"print"},{"value":"1479-6805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}